Skip to content

PR in Endoscopic LAR for Rectal Cancer

Pelvic Floor Reconstruction (PR) in Endoscopic Low Anterior Resection for Rectal Cancer

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04078828
Enrollment
10
Registered
2019-09-06
Start date
2019-09-01
Completion date
2022-04-01
Last updated
2021-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Carcinoma

Keywords

minimally invasive surgical

Brief summary

The anastomotic leakage remains the major early complication after laparoscopic anterior resection(LAR) for medium & low rectal cancer. Pelvic floor reconstruction (PR) is a key step in various standard resections for open radical rectal cancer surgery, which was considered to be helpful for decreasing the rate of leakage. However, PR in endoscopic LAR surgery is not routine practice and remains controversial. The purpose of this study is to evaluate the efficacy of PR during LAR for mid/low rectal carcinoma, especially in preventing anastomotic leakage.

Detailed description

Eligible patients with rectal cancer will be randomly assigned to group with pelvic floor reconstruction(PR) versus group without pelvic floor reconstruction(NPR). We want to investigate the rate of anastomotic leakage and re-operation between the two groups, some other relevant outcomes will be concerned all the same.

Interventions

PROCEDUREPelvic floor Reconstruction

Pelvic floor Reconstruction after laparoscopic anterior resection and double-stapling technique anastomosis were finished.

Sponsors

Southwest Hospital, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. patients with histologically proven rectal adenocarcinoma 2. tumor located in the middle and lower rectum and anastomosis under the peritoneal reflection 3. Tumor assessed as a depth of invasion that was confined to pT1-pT3, bN0-1M0 by ultrasound colonoscopy and/or pelvic MRI 4. Negative circumferential resection margin confirmed by MRI 5. Performance status (ECOG) 0\ 1 6. Written informed consent for participation in the trial

Exclusion criteria

1. History of accepting lower abdominal surgery. 2. More than one colorectal tumor 3. Patients with unresectable distant metastasis or multiple metastases 4. Received neoadjuvant radiotherapy before surgery 5. Signs of acute intestinal obstruction, bleeding or perforation needing emergency surgery 6. Patients and/or family members cannot understand and accept this study 7. Non-rectal adenocarcinoma was confirmed by postoperative pathological examination

Design outcomes

Primary

MeasureTime frame
The rate of anastomotic leakage after laparoscopic anterior resection for rectal cancer30 days after surgery
Re-operation rate after anastomotic leakage30 days after surgery
The rate of general complications30 days after surgery

Secondary

MeasureTime frame
3-year local recurrence rateFrom date of operation until the date of local-recurrence (up to 3 years)
5-year disease-free survivalFrom date of operation until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 5 years
Operative timeOperation day
Blood lossOperation day
White blood cells(WBC) ,C-reactive protein (CRP) and procalcitonin (PCT) count in the blood sample1 days after surgery
Postoperative quality of life as assessed by EORTC QLQ-C30 questionnaire1 year after operation
Postoperative hospital stay1 year after surgery
Incidence of defecation dysfunctionFrom the date of operation until the date of complication,assessed up to 3 years

Countries

China

Contacts

Primary ContactTang Bo, MD
tangtbo@sina.com+862368754167
Backup ContactLi Chuan, MD
79168391@qq.com+862368754167

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026